Arterial Remodeling Technologies ('ART') signs structured buyout agreement with Terumo, validating ART's next-gen bioresorbable scaffold
Business Wire - Thu Mar 27, 8:44AM CDT
Privately held Arterial Remodeling Technologies ('ART') announced today that it has signed a structured buyout agreement with Terumo Corporation. Under the agreement, ART and Terumo Corporation will collaborate in the development of a drug eluting bioresorbable scaffold or stent, intended for use in the treatment of coronary artery disease. ART Security Holders will retain full ownership of the ART bioresorbable scaffold technology for all other indications. Terumo Corporation will make staged R&D investments in ART and ART has granted an exclusive option to Terumo Corporation to purchase ART at any time prior to the initiation of clinical trials.
Drug Device Combination Products Market Report 2013 - 2019: Forecasts & Trends for the $US100 Billion Market
M2 - Tue Mar 18, 11:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wmt3kk/drug_device) has announced the addition of the "Drug Device Combination Products Market Report 2013 - 2019: Forecasts & Trends for the $US100 Billion Market" report to their offering. The global drug device combination products market was valued at USD 66 billion in 2012 and is expected to grow at a CAGR of 7.9% from 2013 to 2019, to reach an estimated value of USD 115 billion in 2019. This report studies the global market for drug device combination products from the perspective of product types. The market is thus segmented into drug eluting stents, infusion pumps, bone graft implants, photodynamic therapy, wound care combination devices, inhalers, transdermal patches and others including intraocular implants and drug eluting beads. The market for all these product segments is also analyzed for four major geographic regions namely North America, Europe, Asia and the rest of the world (RoW) regions. The markets for all these segments is analyzed and estimated in USD billion. Each of the segments have been analyzed on the basis of its current and future market size for the period 2011 to 2019, in terms of revenue generation in USD billion, considering 2011 and 2012 as the base years. The compounded annual growth rate (%CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size. A competitive landscape, mapping all the market players and their respective market shares for 2012 are provided in this report for drug eluting stents and infusion pumps. A chapter on recommendations for existing and new entrants is also provided in this report. Drug Device Combination Products Market: - Drug Eluting Stents - Infusion Pumps - Photosensitizers - Orthopedic Combination Products - Wound Care Combination Products - Inhalers - Transdermal Patches - Intraocular Implants and Drug Eluting Beads Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Drug Device Combination Products, by Type, Size and Forecast, 2011-2019 (USD Billion) Chapter 5 Global Drug Device Combination Products, by Geography, 2011 - 2019 (USD Million) Chapter 6 Competitive Landscape Chapter 7 Recommendations Chapter 8 Company Profiles - Abbott Laboratories - Alcon, Inc. - Allergan, Inc. - Arrow International, Inc. - Bausch & Lomb, Inc. - Boston Scientific Corporation - C.R. Bard, Inc. - CareFusion Corporation - Covidien PLC - Ethicon, Inc. - Medline Industries, Inc. - Medtronic, Inc. - Mylan, Inc. - Pinnacle Biologics, Inc. - Stryker Corporation - Terumo Corporation - W. L. Gore & Associates, Inc. For more information visit http://www.researchandmarkets.com/research/wm...rug_device
Concise Analysis of the International Intravascular Ultrasound (IVUS) Market
M2 - Fri Mar 07, 5:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/mgsk4v/intravascular) has announced the addition of the "Concise Analysis of the International Intravascular Ultrasound (IVUS) Market" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period of 2009 through 2018. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Intravascular Ultrasound (IVUS) in US$ Thousand by the following Product Segments: - Intravascular Ultrasound (IVUS) Catheters - Intravascular Ultrasound (IVUS) Consoles Company profiles are primarily based on public domain information including company URLs. The report profiles 10 companies including many key and niche players such as: - Boston Scientific Corp. - InfraReDx, Inc. - Silicon Valley Medical Instruments, Inc. - Terumo Corp. - Volcano Corp. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Trends & Growth Drivers 3. Issues And Challenges 4. Competitive Landscape 5. Clinical Studies 6. Product Overview 7. Coronary Stents Market - A Brief Overview 8. Product Approvals/Introductions 9. Recent Industry Activity 10. Focus On Select Players 11. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Rest Of World IV. Competitive Landscape Total Companies Profiled: 10 (including Divisions/Subsidiaries - 12) - The United States (7) - Japan (3) - Europe (2) - Germany (1) - Rest of Europe (1) For more information visit http://www.researchandmarkets.com/research/mg...ravascular
Reps Committee Commends CBN On Remmittance
All Africa Global Media - Wed Feb 26, 4:04AM CST
The House of Representatives Committee on Finance on Tuesday commended the Central Bank of Nigeria for its timely remittance to the Federation Account.
EnteroMedics to Present at the Cowen and Company 34th Annual Health Care Conference
Marketwire - Tue Feb 25, 6:01AM CST
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Mark B. Knudson, Ph.D., EnteroMedics' President and Chief Executive Officer, is scheduled to present at the Cowen and Company 34th Annual Health Care Conference on March 5, 2014 at 10:00 am Eastern Time at the Boston Marriott Copley Place in Boston, MA.
EURO RESSOURCES REPORTS EARNINGS FOR THE YEAR ENDED DECEMBER 31, 2013
GlobeNewswire - Fri Feb 21, 5:48PM CST
EURO Ressources S.A. ("EURO" or the "Company") (Paris: EUR) today announced its audited statutory financial results prepared in accordance with French Generally Accepted Accounting Principles ("GAAP") and its audited financial results prepared in accordance with International Financial Reporting Standards ("IFRS") for the year ended December 31, 2013. These audited financial results were approved by the Board of Directors on February 21, 2014. All financial amounts are expressed in Euros unless otherwise specified.
Global Central Venous Access Devices Market 2014-2018: Becton, Dickinson and Co., Cook Medical Inc., C.R Bard Inc. and Teleflex Inc Among Top Vendors
M2 - Mon Feb 17, 9:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/4268p7/global_central) has announced the addition of the "Global Central Venous Access Devices Market 2014-2018" report to their offering. The analysts forecast the Global Central Venous Access Devices market to grow at a CAGR of 4.10 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing aging population. The Global Central Venous Access Devices market has also been witnessing the increased use of antimicrobial catheters. However, the high risk of vein thrombosis could pose a challenge to the growth of this market. Key vendors dominating this space are AngioDynamics Inc., B. Braun Melsungen AG, Becton, Dickinson and Co., Cook Medical Inc., C.R Bard Inc., and Teleflex Inc. Other vendors mentioned in the report are Boston Scientific Corp., Covidien Plc., Edwards Lifesciences Corp., Medical Components Inc., Smiths Medical, Terumo Corp., and Vygon Corp. Commenting on the report, an analyst from the team said: Following the change of reimbursement policies (offered under Medicare and Medicaid) in the recent past, there has been an increase in the use of antimicrobial catheters. According to the changes, reimbursement would no longer be provided for treatment of vascular access-related infections acquired during a patient's hospitalization. The antimicrobial CVCs are inserted directly into the bloodstream through the large internal jugular, subclavian, and femoral veins, making them highly susceptible to infection. The complete CVC kits include maximum barrier drapes, manufactured catheter securement devices, and the antimicrobial agent (chlorhexidine) that is highly adopted by surgeons. The demand for dialysis catheters with intraluminal antimicrobial properties has also increased over the years. In addition, antimicrobial PICCs are extensively used to deliver chemotherapy and antibiotics as well as for drawing blood from immunocompromised patients. According to the report, one of the main drivers in this market is the increasing aging population that has led to an increase in demand for central venous access devices for delivering drugs, nutritional support, or aspiration of blood for sampling. For more information visit http://www.researchandmarkets.com/research/42...al_central About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
BIOLASE Comments on $5 Million Private Placement With Oracle Investment Management, Inc.
Marketwire - Wed Feb 12, 11:16AM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase, and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography and Galaxy CAD/CAM systems for dentistry, today commented on its recent $5 million private placement with Oracle Partners LP.
Concise Analysis of the International Anesthesia Devices Market
M2 - Fri Jan 31, 6:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/9x3jx2/anesthesia) has announced the addition of the "Concise Analysis of the International Anesthesia Devices Market" report to their offering. Anesthesia device product segments analyzed in this study include Delivery Machines, Disposables & Accessories, Monitors and Information Systems. The global market for Anesthesia Devices is estimated at US$7.4 billion in 2013 and forecast to be US$8.1 billion in 2014. Maintaining a CAGR of about 7.5% between 2010 and 2020, Anesthesia Devices market worldwide is further projected to reach US$11.8 billion by 2020. The report reviews, analyses and projects the anesthesia devices market for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 13 independent countries across North America - The United States and Canada; Europe - Germany, the United Kingdom, France, Italy, Spain, Bulgaria, Czech Republic and Hungary; Asia-Pacific - Japan, China and India. The study includes 84 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value in US$ by geographic region and product segment. This report profiles 33 key global players and 39 major players across North America - 17; Europe - 13; Asia-Pacific - 8 and Rest of World - 1. Key Topics Covered: Table Of Contents: Part A: Global Market Perspective 1. Introduction 2. Key Market Trends 3. Key Global Players 4. Key Business Trends 5. Global Market Overview Part B: Regional Market Perspective 1. North America 2. Europe 3. Asia-Pacific 4. Rest Of World Part C: Guide To The Industry 1. North America 2. Europe 3. Asia-Pacific 4. Rest Of World Part D: Annexure 1. Research Methodology 2. The Questionnaire 3. Feedback Companies Mentioned: - Ambu - Baxter International - Becton, Dickinson and Company - Cardinal Health - Dr?gerwerk AG & Co - Esaote SpA - Fisher & Paykel Healthcare Limited - GE Healthcare - Getinge - Hospira - Intersurgical - Kimberly-Clark Health Care - Leventon - Maquet GmbH & Co - Nihon Kohden Corporation - Parker Healthcare - Siare Engineering International Group - Smiths Medical - Sonosite - Teleflex Incorporated - Terumo Corporation - Unomedical For more information visit http://www.researchandmarkets.com/research/9x3jx2/anesthesia
2013 Report on the International Nephrology and Urology Devices Market - Industry Analysis, Size, Share, Trends and Forecast to 2018
M2 - Fri Jan 10, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/t8gg8c/nephrology_and) has announced the addition of the "2013 Report on the International Nephrology and Urology Devices Market - Industry Analysis, Size, Share, Trends and Forecast to 2018" report to their offering. Nephrology and urology devices are commonly used for treatment of kidney and urinary system related problems such as chronic kidney disease (CKD) and end stage renal disease (ESRD), kidney stone, benign prostatic hyperplasia (BPH), urinary incontinence and pelvic organ prolapse. A slow growing awareness of urinary diseases and causes of renal failure has led to a large population suffering from CKD, diabetes and ESRD. Growing market for dialysis due to rising incidences of chronic kidney diseases (CKD) along with increasing aging population is the major driver for this market. Increasing awareness about the benefits such as reduced treatment and recovery time among renal disease patients is also influencing the demand for nephrology and urology devices. Some other driving factors include innovation in urology devices, increasing healthcare spending and growing refurbished devices market particularly for lithotripters in Asia-Pacific and other developing regions. This also leaves consumers in Europe and North America to revamp their clinics and hospitals with new innovative technologies. Aging is the most common factor responsible for all types of urology diseases. It is expected that a large size of population will undergo kidney disease treatment which will increase the demand for these devices across the world. Key Topics Covered: 1 Preface 2 Executive Summary 3 Nephrology and Urology Devices Market Dynamics 4 Nephrology and Urology Devices Market, by Device Type 5 Nephrology and Urology Devices Market, by Geography 6 Market Share Analysis of Key Players, 2011 7 Company Profile Analysis Companies Mentioned: - Asahi Kasei Corp. - B Braun Group - Baxter International Inc. - C. R. Bard Inc. - Cook Group Incorporated - Dornier Medtech - Fresenius Medical Care - Nikkiso Co. Ltd. - Nipro Corporation - Nxstage Medical Inc - Rockwell Medical Technologies, Inc - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/t8...rology_and
2013 Report on the International Blood Processing Devices and Consumables Market - Global Forecast to 2019
M2 - Wed Jan 08, 4:14AM CST
Research and Markets (http://www.researchandmarkets.com/research/lsdz7d/blood_processing) has announced the addition of the "2013 Report on the International Blood Processing Devices and Consumables Market - Global Forecast to 2019" report to their offering. "2013 Report on the International Blood Processing Devices and Consumables Market - Global Forecast to 2019", discusses the devices and consumables used in the process of blood processing, analyzing and storing which include blood administration sets, refrigerators, freezers, blood cell processors, grouping analyzers, coagulation reagents, sedimentation tubes, slide strainers and others. Market size estimates and forecasts for the period 2011 to 2019 has been given for each segment and sub-segments, in terms of USD billion, considering 2012 as the base year. The report also provides the competitive landscape analysis for product types is highlighted and key market players are profiled including attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of the key players for 2012 are provided, and recommendations to accentuate market shares and ensure sustainability are also put forward in this report. Key market player profiles in this report include Terumo BCT, Fresenius Kabi AG, Haemonetics Corporation, Immucor, Inc., MacoPharma SA Abbott Laboratories, Bio-Rad Laboratories and others. Key Topics Covered: 1 Preface 2 Executive Summary 3 Market Overview 4 Blood Processing Devices and Consumables Market, by Products 5 Blood Processing Devices and Consumables Market, by Geography 6 Recommendations 7 Company Profiles Companies Mentioned: - Abbott Laboratories - Becton, Dickinson And Company - Bio-Rad Laboratories - Biomerieux SA - Danaher Corporation - Fresenius Kabi AG - Grifols International, SA - Haemonetics Corporation - Immucor, Inc - Macopharma SA - Roche Holdings AG - Terumo Corporation - Thermogenesis Corporation For more information visit http://www.researchandmarkets.com/research/ls...processing
2013 Report on the International Injectable Drug Delivery Market - Includes Forecasts to 2017
M2 - Thu Jan 02, 4:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/5fj7x3/injectable_drug) has announced the addition of the "2013 Report on the International Injectable Drug Delivery Market - Includes Forecasts to 2017" report to their offering. The injectable drug delivery market is technology driven and is marked by the 'Threat of Obsolescence' wherein technologies as well as its adoption by patients changes very rapidly. The industry has seen a shift in paradigm and is now skewed toward self-injection devices that not only cure serious illnesses but also have fewer serious side effects. The market for injectable drug delivery includes devices and formulations. Traditionally, injectable devices were primarily designed for delivery of insulin and human growth hormones. However, due to technological advancements they are currently being used as combination therapies for the delivery of a wide variety of drug classes such as anticholinergic, hematopoietic, dopamine agonists, parathyroid hormones, reproductive hormones, serotonin antagonists, sympathomimetic and immune modulators. Self injection devices including auto injectors and pen injectors are the fastest growing segments in the injectable drug delivery market. In recent years, the uptake and adoption of self-injection devices such as auto and pen injectors has grown substantially. This is due to the benefits it offers over conventional injection devices. Self-injection devices ensure better patient adherence to treatment due to decrease risk of missed injection or drug discontinuation, and reduced healthcare cost as costly hospital visits are curtailed. This has ignited the interest of device manufacturers who are in turn incessantly coming up with new variants of self-injection devices with advanced technological features. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Injectable Drug Delivery Devices Technologies Market 5 Global Injectable Drug Delivery Formulation Technologies Market 6 Global Injectable Drug Delivery Technologies Market, By Therapeutic Applications 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles Companies Mentioned: - Alkermes - Antares Pharma - Baxter International - Becton, Dickinson And Company - Bespak Europe - Crossject - Elcam Medical - Eli Lilly And Company - Gerresheimer - Haselmeier - Injex Pharma - Novo Nordisk - Owen Mumford - Sanofi - Schott - Shl Group - Terumo Corporation - Unilife Corporation - Vetter Pharma-Fertigung - West Pharmaceutical Services - Ypsomed Holding - Zogenix For more information visit http://www.researchandmarkets.com/research/5f...table_drug
Global Intravascular Ultrasound (IVUS) Strategic Business Report 2013-2018
M2 - Fri Dec 20, 6:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/t2m66g/intravascular#summary) has announced the addition of the "Intravascular Ultrasound (IVUS) - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period of 2009 through 2018. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Intravascular Ultrasound (IVUS) in US$ Thousand by the following Product Segments: - Intravascular Ultrasound (IVUS) Catheters - Intravascular Ultrasound (IVUS) Consoles. The report profiles 10 companies including many key and niche players such as: - Boston Scientific Corp. - InfraReDx, Inc. - Silicon Valley Medical Instruments, Inc. - Terumo Corp. - Volcano Corp. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Trends & Growth Drivers 3. Issues And Challenges 4. Competitive Landscape 5. Clinical Studies 6. Product Overview 7. Coronary Stents Market - A Brief Overview 8. Product Approvals/Introductions 9. Recent Industry Activity 10. Focus On Select Players 11. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Rest Of World IV. Competitive Landscape Total Companies Profiled: 10 (including Divisions/Subsidiaries - 12) - The United States (7) - Japan (3) - Europe (2) - - Germany (1) - - Rest of Europe (1) For more information visit http://www.researchandmarkets.com/research/t2...ar#summary
MediPoint Report 2013: Renal Denervation - South American Analysis and Market Forecasts
M2 - Tue Dec 17, 8:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/55lp22/medipoint_renal) has announced the addition of the "MediPoint: Renal Denervation - South American Analysis and Market Forecasts" report to their offering. The renal denervation market in Brazil will grow to $6.7m in 2019 from nothing in 2012. Numerous medical device news sources and industry executives have proclaimed renal denervation to be the top medical device breakthrough of the past two years, and for good reason. Hypertension is one of the most prevalent chronic conditions worldwide, with some studies estimating that 50% of the adult population globally will have the disease in the next 20 years. With limited effectiveness from pharmacotherapy, medical device therapy has the potential for significant adoption in the treatment of resistive hypertension and uncontrolled hypertension, once efficacy and cost-effectiveness are proven. Additionally, the degree of blood pressure reduction found in long-term clinical trials from such a well-tolerated procedure has generated notable optimism about the intervention's application in other conditions where hyperactivity of the sympathetic nervous system plays a significant role, such as congestive heart failure. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Disease Overview 4 Marketed Products - Allegra Renal Denervation System (Terumo/AngioCare) - EnligHTN Renal Denervation System (St. Jude Medical) - OneShot Renal Denervation System (Covidien) - Paradise Renal Denervation System (ReCor Medical) - Symplicity Renal Denervation System (Medtronic) - Vessix Renal Denervation System (Boston Scientific Corporation) 5 Unmet Needs 6 Pipeline Products - Beta-Cath System (Best Medical International) - Bullfrog MicroFusion Catheter (Mercator MedSystems) - Chemical Denervation System (Kipprokration Hospital) - Cryoablation System (Cryomend) - Kona Surround Sound System (Kona Medical) - Magnetic Nanoparticles (ApexNano) - Perivascular Renal Denervation System (Ablative Solutions) - Sound 360 Ultrasonic Renal Denervation System (Sound Interventions) - Symple Surgical System (Symple Surgical) - Tivus System (Cardiosonic) - Celsius ThermoCool System (Cordis/Johnson & Johnson) - Northwind Medical System (Northwind Medical) - Verve Medical System (Verve Medical) 7 Clinical Trial Analysis 8 Industry Overview 9 Current and Future Players - Ablative Solutions - ApexNano - Best Medical International - Boston Scientific Corporation - Cardiosonic - Covidien - Cordis Corporation and Johnson & Johnson - Cryomend - Kona Medical - Medtronic - Mercator MedSystems - Northwind Medical - ReCor Medical - Sound Interventions - St. Jude Medical - Symple Surgical - Terumo Corporation - Verve Medical 10 Market Drivers and Opportunities 11 Country Outlooks and Forecasts 12 Appendix For more information visit http://www.researchandmarkets.com/research/55...oint_renal
Renal Denervation - Current and Future Players
M2 - Fri Dec 06, 6:05AM CST
Research and Markets (http://www.researchandmarkets.com/research/93sh5f/medipoint_renal) has announced the addition of the "Renal Denervation - Current and Future Players" report to their offering. Numerous medical device news sources and industry executives have proclaimed renal denervation to be the top medical device breakthrough of the past two years, and for good reason. Hypertension is one of the most prevalent chronic conditions worldwide, with some studies estimating that 50% of the adult population globally will have the disease in the next 20 years. With limited effectiveness from pharmacotherapy, medical device therapy has the potential for significant adoption in the treatment of resistive hypertension and uncontrolled hypertension, once efficacy and cost-effectiveness are proven. Additionally, the degree of blood pressure reduction found in long-term clinical trials from such a well-tolerated procedure has generated notable optimism about the intervention's application in other conditions where hyperactivity of the sympathetic nervous system plays a significant role, such as congestive heart failure. The report identifies and analyzes the key companies shaping and driving the global renal denervation market. The report provides insight into the competitive renal denervation landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading cardiologists, with in-house analysis conducted by Our team of industry experts. Scope - Investigation of current and future market competition for renal denervation - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists using renal denervation devices in clinical practice. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Marketed Products 4 Pipeline Products 5 Current and Future Players 6 Appendix Companies Mentioned: - Ablative Solutions - ApexNano - Best Medical International - Boston Scientific Corporation - Cardiosonic - Covidien - Cordis Corporation and Johnson & Johnson - Cryomend - Kona Medical - Medtronic - Mercator MedSystems - Northwind Medical - ReCor Medical - Sound Interventions - St. Jude Medical - Symple Surgical - Terumo Corporation - Verve Medical For more information visit http://www.researchandmarkets.com/research/93...oint_renal
Peripheral Vascular Stents - Global Analysis and Market Forecasts - 2013: The Iliac and Femoropopliteal Vascular Stent Markets Expected to Increase to Over $1 Billion By 2019
M2 - Wed Dec 04, 10:07AM CST
Research and Markets (http://www.researchandmarkets.com/research/gtf7kg/medipoint) has announced the addition of the "MediPoint: Peripheral Vascular Stents - Global Analysis and Market Forecasts" report to their offering. Global Peripheral Vascular Stent Market Currently, BMS have the largest market share in the global peripheral vascular stent market for the lower extremity, followed by covered stents. The BMS market is an approximately $1.5 billion market that is more than three to 10 times the size of the covered and drug-eluting stent markets, respectively. Self-expanding nitinol stents account for over 60% of BMS used to treat iliac, femoropopliteal, and infrapopliteal artery lesions. Covered stents have been used for specific cases where the patient has good run-off, including treating atherosclerotic disease in the common iliac arteries and in-stent restenosis. Drug-eluting and bioabsorbable stent currently have the smallest market shares. However, as adoption of these stent technologies increases in the future, they will take market share away from bare metal and covered stents. Among the peripheral artery indications in the lower extremity, the iliac and femoropopliteal arteries currently have the largest market share in the peripheral vascular stent market. The iliac and femoropopliteal vascular stent markets are expected to increase to over $1 billion by 2019. Given the challenges in treating the femoropopliteal arteries, the femoropopliteal vascular stent market is an attractive market for drug-eluting and bioabsorbable stents. The adoption of stents for infrapopliteal lesions is lower than for iliac and femoropopliteal lesions. The iliac and femoropopliteal vascular stent markets are approximately three times the size of the infrapopliteal vascular stent market. Balloon angioplasty still remains the preferred method of treatment for treating infrapopliteal (below-the-knee [BTK]) lesions. Companies Mentioned: - Abbott Vascular - Amaranth Medical - Arterial Remodeling Technologies - Atrium Medical Corporation - Bard Peripheral Vascular (C.R. Bard) - Biotronik - Boston Scientific Corporation - 3D Biotek - 480 Biomedical - Cook Medical - Cordis Corporation (Johnson & Johnson) - CorInnova - Covidien - Cytograft Tissue Engineering - Flexible Stenting Solutions - IDEV Technologies - Kyoto Medical Planning - Medtronic - Nexeon Stent - Nipro Corporation - NovoStent Corporation - OptiMed - PeriTec Biosciences - Synergy Flow - Tepha - Terumo Corporation - TissueGen - Translumina - Vascular Concepts - Veryan Medical - VueKlar Cardiovascular - W.L. Gore & Associates - Zorion Medical For more information visit http://www.researchandmarkets.com/research/gtf7kg/medipoint About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MediPoint Report: Renal Denervation - APAC Analysis and Market Forecasts to 2018
M2 - Fri Nov 29, 9:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/r6f2xh/medipoint_renal) has announced the addition of the "MediPoint: Renal Denervation - APAC Analysis and Market Forecasts" report to their offering. Numerous medical device news sources and industry executives have proclaimed renal denervation to be the top medical device breakthrough of the past two years, and for good reason. Hypertension is one of the most prevalent chronic conditions worldwide, with some studies estimating that 50% of the adult population globally will have the disease in the next 20 years. With limited effectiveness from pharmacotherapy, medical device therapy has the potential for significant adoption in the treatment of resistive hypertension and uncontrolled hypertension, once efficacy and cost-effectiveness are proven. Additionally, the degree of blood pressure reduction found in long-term clinical trials from such a well-tolerated procedure has generated notable optimism about the intervention's application in other conditions where hyperactivity of the sympathetic nervous system plays a significant role, such as congestive heart failure. The renal denervation market in the APAC will grow from essentially nothing in 2012 as the intervention was not approved for any indication in 2012. That is expected to change by the end of the forecast period. The entire market will be driven by the adoption of the intervention by resistant hypertension patients. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Disease Overview 4 Marketed Products 5 Unmet Needs 6 Pipeline Products 7 Clinical Trial Analysis 8 Industry Overview 9 Current and Future Players 10 Market Drivers and Opportunities 11 Country Outlooks and Forecasts Companies Mentioned - Ablative Solutions - ApexNano - Best Medical International - Boston Scientific Corporation - Cardiosonic - Covidien - Cordis Corporation and Johnson & Johnson - Cryomend - Kona Medical - Medtronic - Mercator MedSystems - Northwind Medical - ReCor Medical - Sound Interventions - St. Jude Medical - Symple Surgical - Terumo Corporation - Verve Medical For more information visit http://www.researchandmarkets.com/research/r6...oint_renal
Spain Patient Monitoring and Diagnostic Systems Market Growth and Forecast To 2018: Blood Pressure Monitors, Remote Monitoring Systems and More
M2 - Fri Nov 22, 8:18AM CST
Research and Markets (http://www.researchandmarkets.com/research/698brc/spain_patient) has announced the addition of the "Spain Patient Monitoring and Diagnostic Systems Market Growth and Forecast To 2018" report to their offering. The Market Intelligence report provides critical market data for Spain patient monitoring and diagnostics market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends. It covers important categories such as blood pressure monitors, cardiovascular monitoring systems, blood glucose monitoring devices, hearing diagnostics, micro-electromechanical systems multiparameter patient monitors, remote monitoring systems, sleep apnea diagnostic systems and wireless hospital ambulatory monitors. - Market Size Market size in terms of value ($) and volume (units), for each level of segmentation from 2005 to 2012 and forecast till 2018. - Market Growth Market growth in terms of value ($) and volume (units), for each level of segmentation from 2005 to 2012 and forecast till 2018. - Competitive Analysis Market share (%) of companies is covered at sector and category level for 2012. - Pricing Analysis Average selling price ($) for each product type from 2005 - 2012 and forecast till 2018. - Cross category comparison and cross sub-category comparison - Forecast and historic market growth and market size comparison for various categories and sub-categories from 2005 to 2012 and 2012 to 2018. Patient Monitoring and Diagnostics Market Segmentation Companies Mentioned: - A&D Medical - Abbott Laboratories - Apex Biotechnology Corp - Astro-Med, Inc. - Bayer HealthCare AG - BIOTRONIK GmbH & Co. KG - Boston Scientific Corporation - Card Guard AG - Cardiac Science Corporation - Cardinal Health, Inc. - Compumedics Limited - Covidien Ltd. - Criticare Systems, Inc. - Drager Medical AG & Co. KG - Edwards Lifesciences Corporation - Embla Systems - F. Hoffmann-La Roche Ltd - Fukuda Denshi Co., Ltd. - GE Healthcare - GE Sensing - GN ReSound A/S - Hartmann Group - LifeScan, Inc. - Matsushita Electrical Inddustrial Co., Ltd. - Medtronic, Inc. - Microlife Corporation - Mindray Medical International Limited - Natus Medical Incorporated - Nihon Kohden Corporation - OMRON HEALTHCARE Co., Ltd. - OSI Systems, Inc. - Philips Medical Systems - Schiller AG - St. Jude Medical Inc. - Terumo Corporation - Welch Allyn Inc. - William Demant Holding A/S For more information visit http://www.researchandmarkets.com/research/69...in_patient About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research Report: China Diabetes Market Outlook 2018
M2 - Wed Nov 20, 3:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/ngw4st/china_diabetes) has announced the addition of the "China Diabetes Market Outlook 2018" report to their offering. Approximately 92 Million people in China had diabetes in 2012 and the number is estimated to reach approximately 130 Million by 2030. The country's diabetic population is rapidly growing owing to factors including growing ageing population, rising obesity rates and increasing westernization. Not only this, the country has a significant share in the diabetes market globally. Chinese government authorities are spending a huge amount of money on diabetics. The growth in diabetes drug spending in the country is currently running at 11% and is estimated to reach approximately US$ 4.6 Billion by 2018. In this latest report China Diabetes Market Outlook 2018, the country's diabetes market has been segmented into oral drugs, insulin drugs, insulin delivery devices and self-monitoring glucose monitoring devices. The authors have identified the growth potential of diabetes with respect to each of these segments thereby highlighting the potential for market players. The report also highlights the healthcare expenditures pertaining to diabetes treatment in the country which will help clients in understanding the future demand scenario. The report provides an exhaustive overview of the technological developments for insulin delivery devices and glucose monitoring systems which would help the client understand various advanced technology systems available in the market. The overall study analyses the current and future outlook of diabetes drugs as well as insulin delivery device systems in China. The report covers the major drivers and trends impacting the China diabetes market. It provides an insight into strategic activities by major market players. Several companies have been trying to tap the potential market demand for diabetes treatment. However, market players have been extending their product portfolios in order to gain their own market shares. The authors conclude with a competitive analysis of major market players providing their business overviews specific to the China diabetes market along with their product portfolios. It also elucidates the key developments of the players pertaining to this market and provides an overview of the regulatory environment for diabetes and patient profile that will help clients in formulating market strategies and in assessing opportunity areas in the China diabetes market. Key Topics Covered: Analyst View Research Methodology Patient Profile Analysis Cost Implications Market Drivers and Trends Diabetes Drugs Market Insulin Delivery Devices Market Glucose Monitoring Devices Market Government Regulations and Initiatives Key Players List of Charts Companies Mentioned - Bayer - Eli Lilly - Medtronic - Merck & Co. - Novo Nordisk - Sanofi-Aventis - Terumo Corporation - Tianjin Takeda Pharmaceuticals Co Ltd. - Tonghua Dongbao Pharmaceutical Co. Ltd. For more information visit http://www.researchandmarkets.com/research/ng...a_diabetes About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Temperature Monitoring Devices Business to 2018: Time for Smart, No-Fuss Thermometers
M2 - Tue Nov 19, 9:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/fjt82d/temperature#summary) has announced the addition of the "Temperature Monitoring Devices - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Temperature Monitoring Devices in US$ Thousand by the following Product Segments: - Digital Thermometers - Infrared Thermometers - Electronic Temperature Monitors - Temperature Strips. The report profiles 72 companies including many key and niche players such as: - 3M Co. - A&D Medical/LifeSource - Actherm, Inc - American Diagnostic Corporation - Briggs Healthcare - Covidien plc - Exergen Corporation - Geratherm Medical AG - Hicks Thermometers (India) Limited - Kaz USA, Inc. - CR Hallcrest, LLC. - Microlife Corporation - Omron Healthcare, Inc - Mediaid, Inc. - RG Medical Diagnostics - Terumo Corporation - Welch Allyn, Inc. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. An Introduction To Thermometers 3. Product Overview 4. Product Introductions/Innovations 5. Recent Industry Activity 6. Focus On Select Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 72 (including Divisions/Subsidiaries - 91) - The United States (32) - Canada (2) - Japan (5) - Europe (31) - - France (1) - - Germany (7) - - The United Kingdom (10) - - Italy (3) - - Spain (1) - - Rest of Europe (9) - Asia-Pacific (Excluding Japan) (18) - Latin America (1) - Africa (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/fj...re#summary